PhaseV debuted an AI-driven platform, “AI Conductor,” designed to automate end-to-end clinical development workflows—from protocol development and data harmonization through ICH E9 compliance and case report generation. The company says the system is integrated into its broader clinical trial platform and supports submission readiness by enforcing document consistency and pulling from a knowledge base.